Ozette

“High-Resolution Immune Profiling”

Ozette’s immune profiling platform uses cutting edge A.I. to analyze proteins 100x faster and provide insights that answer pressing questions for scientists—such as why a therapy works for one patient but not another. The goal is to significantly increase the overall throughput of drugs and therapies for pharma companies and improve the overall clinical trial success rate (currently FDA only approves 14%).

Learn More   Geekwire Article

Founders

Ali Ansary, PhD

Ali Ansary, PhD

Greg Finak, PhD

Greg Finak, PhD

Raphael Gottardo, PhD

Raphael Gottardo, PhD

Opportunities

If you’re ready to build an AI-first startup, then we want to talk to you

We invite talented engineers, researchers, and entrepreneurs to join our incubator on a rolling basis. If you have ever thought of starting an AI-first company, now is the time.

Apply Now